Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 26, 2009 14:30 ET | Source: Avigen, Inc.

Avigen's Board of Directors to Review BVF Offer and Provide Recommendation

ALAMEDA, Calif., Jan. 26, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today confirmed that BVF Acquisition LLC, a wholly owned subsidiary of Biotechnology Value...
January 14, 2009 13:32 ET | Source: Avigen, Inc.

Avigen Retains Independent Strategic Advisors

ALAMEDA, Calif., Jan. 14, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, announced today that its Board of Directors has retained two independent financial advisors...
December 22, 2008 08:00 ET | Source: Avigen, Inc.

Avigen Board and Management Comment On the Company's Strategic Plans

ALAMEDA, Calif., Dec. 22, 2008 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today announced that its Board of Directors and Management issued the following comments in...
December 18, 2008 08:00 ET | Source: Avigen, Inc.

Avigen Sells Early Stage Research Program in Hemophilia to Baxter

ALAMEDA, Calif., Dec. 18, 2008 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, announced today that the company has sold the rights to its early stage blood coagulation...
December 03, 2008 08:00 ET | Source: Avigen, Inc.

Avigen to Present At RBC Capital Markets Healthcare Conference

ALAMEDA, Calif., Dec. 3, 2008 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, announced today that President and Chief...
November 03, 2008 13:30 ET | Source: Avigen, Inc.

Avigen Announces Restructuring and Strategic Direction

ALAMEDA, Calif., Nov. 3, 2008 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, today announced a significant restructuring of...
October 28, 2008 08:00 ET | Source: Avigen, Inc.

Avigen Reports Third Quarter 2008 Financial Results

ALAMEDA, Calif., Oct. 28, 2008 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, today reported financial results for its third...
October 21, 2008 06:30 ET | Source: Avigen, Inc.

Avigen Announces AV650 Did Not Meet Efficacy Endpoints in Phase 2b Clinical Trial for Spasticity in Patients With Multiple Sclerosis

ALAMEDA, Calif., Oct. 21, 2008 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, today announced that the top-line data from...
October 15, 2008 08:00 ET | Source: Avigen, Inc.

Avigen Initiates Opioid Withdrawal Trial in Partnership With NIDA, Columbia University and the New York State Psychiatric Institute

ALAMEDA, Calif., Oct. 15, 2008 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, today announced the launch of an exploratory...
September 18, 2008 08:00 ET | Source: Avigen, Inc.

Avigen Completes Multi-Center AV650 Phase 2b Spasticity Trial in Patients With Multiple Sclerosis

ALAMEDA, Calif., Sept. 18, 2008 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, today announced the completion of the...